[go: up one dir, main page]

AU2001255234A1 - Cellular calcium responce for diagnosis of alzheimer's disease - Google Patents

Cellular calcium responce for diagnosis of alzheimer's disease

Info

Publication number
AU2001255234A1
AU2001255234A1 AU2001255234A AU5523401A AU2001255234A1 AU 2001255234 A1 AU2001255234 A1 AU 2001255234A1 AU 2001255234 A AU2001255234 A AU 2001255234A AU 5523401 A AU5523401 A AU 5523401A AU 2001255234 A1 AU2001255234 A1 AU 2001255234A1
Authority
AU
Australia
Prior art keywords
responce
alzheimer
diagnosis
disease
cellular calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001255234A
Other languages
English (en)
Inventor
Daniel L. Alkon
Barry Bank
Seetha Bhagavan
Rene Etcheberrigaray
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NeuroLogic Inc
Original Assignee
NeuroLogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NeuroLogic Inc filed Critical NeuroLogic Inc
Publication of AU2001255234A1 publication Critical patent/AU2001255234A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896Neurological disorders, e.g. Alzheimer's disease
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705Assays involving receptors, cell surface antigens or cell surface determinants
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/28Neurological disorders
    • G01N2800/2814Dementia; Cognitive disorders
    • G01N2800/2821Alzheimer

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2001255234A 2000-04-05 2001-04-05 Cellular calcium responce for diagnosis of alzheimer's disease Abandoned AU2001255234A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19462600P 2000-04-05 2000-04-05
US60/194,626 2000-04-05
PCT/US2001/011060 WO2001077686A2 (fr) 2000-04-05 2001-04-05 Coefficient de reponse cellulaire au calcium pour le diagnostic et le pronostic de la maladie d'alzheimer

Publications (1)

Publication Number Publication Date
AU2001255234A1 true AU2001255234A1 (en) 2001-10-23

Family

ID=22718298

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001255234A Abandoned AU2001255234A1 (en) 2000-04-05 2001-04-05 Cellular calcium responce for diagnosis of alzheimer's disease

Country Status (2)

Country Link
AU (1) AU2001255234A1 (fr)
WO (1) WO2001077686A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5598200B2 (ja) 2010-09-16 2014-10-01 ソニー株式会社 データ処理装置、データ処理方法、およびプログラム
CN116469540B (zh) * 2023-03-30 2023-11-14 北京透彻未来科技有限公司 基于双阈值的去噪方法及系统

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6107050A (en) * 1993-05-03 2000-08-22 The United States Of America As Represented By The Department Of Health And Human Services Diagnostic test for alzheimers disease
US5976816A (en) * 1993-05-03 1999-11-02 The United States Of America As Represented By The Department Of Health And Human Services Cell tests for alzheimer's disease
US5580748A (en) * 1993-05-03 1996-12-03 The United States Of America As Represented By The Department Of Health And Human Services Diagnostic tests for alzheimers disease
WO1999024830A1 (fr) * 1997-11-10 1999-05-20 Bristol-Myers Squibb Company Procede pour diagnostiquer la maladie d'alzheimer

Also Published As

Publication number Publication date
WO2001077686A2 (fr) 2001-10-18
WO2001077686A3 (fr) 2002-08-29

Similar Documents

Publication Publication Date Title
AU2001273132A1 (en) Compounds to treat alzheimer's disease
EE200200716A (et) Ühendid Alzheimeri tõve käitluseks
AU2001233299A1 (en) Methods for treating alzheimer's disease
AU2001284646A1 (en) Quinuclidine-substituted heteroaryl moieties for treatment of disease
AU2002219824A1 (en) Compositions and methods for diagnosing alzheimer's disease
IL188506A0 (en) Use of an immunogen for preparation of pharmaceutical composition for treating alzheimer's disease
HUP0301020A3 (en) Early diagnosis of conformational diseases
AU2610901A (en) Predictive diagnostic for alzheimer's disease
AU2001236592A1 (en) Methods for diagnosis of alzheimer's disease
AU2002315131A1 (en) Aminediols as agents for the treatment of alzheimer's disease
AU3173301A (en) Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity
AU2001273661A1 (en) Methods of screening for alzheimer's disease
AU2002335794A1 (en) Allylamides useful in the treatment of alzheimer's disease
AU2001264950A1 (en) Methods of screening for parkinson's disease
AU2002212471A1 (en) Peptides for use in the treatment of alzheimer's disease
AU2002222108A1 (en) Diagnosis and treatment of alzheimer's disease
AU2003273310A1 (en) Substituted aminoethers for the treatment of alzheimer's disease
IL141950A0 (en) Diagnosis of prion diseases
AU2001255234A1 (en) Cellular calcium responce for diagnosis of alzheimer's disease
AUPR202400A0 (en) Method of screening for inhibitors of alzheimer's disease
AU2003299101A1 (en) Compounds for the treatment of alzheimer's disease
AU2001267826A1 (en) Remedies for alzheimer's disease
HUP0103149A3 (en) Pharmaceutical composition for treatment of alzheimer's disease
AU2001253219A1 (en) Composition for treatment of autoimmune disease
AU2001258569A1 (en) Alzheimer's disease assay